Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?

NCT02812784 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.

NCT NCT02812784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02812784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Phase
Observational
Overall status
Completed
Start date
September 16, 2015
Completion date
February 11, 2019
Enrollment
184 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

heading